Kloner RA, Goldstein I, Kirby MG. et al. Cardiovascular safety of phosphodiesterase type 5 inhibitors after nearly 2 decades on the market. Sex Med Rev 2018; DOI: 10.1016/j.sxmr.2018.03.008. [Epub ahead of print]
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.